Structure–activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor
摘要:
5-F substitution of an aminothiazole moiety within a series of thrombopoietin receptor agonists leads to potent agents with an improved hepatic safety pro. le in rodent toxicology studies. (C) 2010 Elsevier Ltd. All rights reserved.
[EN] AMINOTHIAZOLE DERIVATIVES AS AGONISTS OF THE THROMBOPOIETIN RECEPTOR<br/>[FR] DÉRIVÉS D'AMINOTHIAZOLE EN TANT QU'AGONISTES DU RÉCEPTEUR DE LA THROMBOPOÏÉTINE
申请人:PFIZER PROD INC
公开号:WO2007036769A1
公开(公告)日:2007-04-05
[EN] A compound of the formula (I) wherein R1, R2, R3, X, Y, and d are defined as above. The presently disclosed compounds are TPO agonists useful as promoters of thrombopoiesis and megakaryocytopoiesis. [FR] La présente invention porte sur un composé de formule (I) où R1, R2, R3, X, Y et d sont tels que définis ci-dessus. Lesdits composés sont des agonistes de TPO pouvant être employés en tant que promoteurs de la thrombopoïèse et de la mégacaryocytopoïèse.
WO2007/36769
申请人:——
公开号:——
公开(公告)日:——
Structure–activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor
作者:Amy S. Antipas、Laura C. Blumberg、William H. Brissette、Matthew F. Brown、Jeffrey M. Casavant、Jonathan L. Doty、James Driscoll、Thomas M. Harris、Christopher S. Jones、Sandra P. McCurdy、Eric McElroy、Mark Mitton-Fry、Michael J. Munchhof、David A. Reim、Lawrence A. Reiter、Sharon L. Ripp、Andrei Shavnya、Marc I. Smeets、Kristen A. Trevena
DOI:10.1016/j.bmcl.2010.05.087
日期:2010.7
5-F substitution of an aminothiazole moiety within a series of thrombopoietin receptor agonists leads to potent agents with an improved hepatic safety pro. le in rodent toxicology studies. (C) 2010 Elsevier Ltd. All rights reserved.